For lung cancer screening, outcomes were receipt of LDCT (CPT codes G0297, S8032, 71271) in enrollees who had not had a chest CT in the prior 11 months.23 Chest CTs were identified by CPT/ HCPCS codes (G0297, S8032, 71271, 71250, 71260, 71270) or ICD-10-CM codes BW2400Z, BW...
population and to identify characteristics of lung cancer screening programs (i.e., screen frequency and adherence, eligibility, follow-up program, effects on cessation, and costs) with the largest influences on the cost-effectiveness of screening. We compared smoking cessation therapies with screening...
Lung cancer is the leading cause of cancer-related mortality in both men and women in the United States, accounting for more than 28% of all cancer deaths in 2000. The estimated number of new cases of lung cancer in 2000 is 164,100 with an estimated 156,
24 In summary, an actuarial analysis of actual cost of screening services based on current relevant Current Procedural Terminology (CPT) codes, shows that LDCT screening done in a fashion consistent with an International Early Lung Cancer Action Program or National Comprehensive Cancer Network protocol...
Melamed MR. Lung cancer screening results in the National Cancer Institute New York study. Cancer (Phila) 2000;89:2356–2362. ArticlePubMedCASGoogle Scholar Frost JK, Ball WCJ, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening...
Screening Trial (NLST) reported that screening with annual, low-dose, spiral CT scans decreased lung cancer–specific mortality and all-cause mortality in asymptomatic high-risk individuals (http://www.cancer.gov/newscenter/qa/2002/nlstqaQA) (see the NCCN Lung Cancer Screening Guideline).22 ...
Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. BACKGROUND: Lung cancer is the leading cause of cancer-related death in the United States and worldwide. No major professional organizations, ...
A case of small-cell lung cancer responding remarkably to CPT-11 and CDDP combination chemotherapyAntineoplastic Combined Chemotherapy ProtocolsCarcinomaSmall CellLung Neoplasms癌小细胞肺肿瘤A 73-year-old man was admitted to our hospital complaining of general malaise, loss of appetite and body weight ...
CPT-11 has also been found to be active in leukemia, lymphoma, SCLC, non-small cell lung cancer, colorectal cancer, ovarian cancer, and cervical cancer. CPT-11 has also demonstrated schedule-dependent antitumor activity and toxicity in preclinical animal models. On this basis, we carried out ...
Carboxylesterase (CE) catalyses the conversion of CPT-11 to SN-38 (7-ethyl-10-hydroxycamptothecin), the active form of CPT-11. The antiproliferative effects of CPT-11 and SN-38, CE-activity and topoisomerase I protein expression were investigated in five human small-cell lung cancer (SCLC) ...